113 related articles for article (PubMed ID: 1433895)
1. [Clinical evaluation of flucytosine in patients with urinary fungal infections].
Tokunaga S; Ohkawa M; Nakashima T; Yamaguchi K; Nishikawa T; Matsushita T; Mikawa I; Hirano S; Kawaguchi S; Miyagi T
Jpn J Antibiot; 1992 Aug; 45(8):1060-4. PubMed ID: 1433895
[TBL] [Abstract][Full Text] [Related]
2. [Fungal urinary infection: report no. 1].
Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
Hinyokika Kiyo; 1986 Oct; 32(10):1543-6. PubMed ID: 3565191
[TBL] [Abstract][Full Text] [Related]
3. [Flucytosine in the treatment of urinary fungal infections. Clinical efficacy and background factors].
Fujihiro S; Ehara H; Saito A; Ito Y; Kanematu M; Ban Y; Kawada Y
Jpn J Antibiot; 1991 Jan; 44(1):14-21. PubMed ID: 2041144
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy of flucytosine on urinary candidiasis].
Yasumoto R; Asakawa M; Umeda M; Tanaka S; Tsurusaki K; Mori K; Kakinoki K; Kawashima H
Hinyokika Kiyo; 1988 Sep; 34(9):1679-82. PubMed ID: 3213801
[TBL] [Abstract][Full Text] [Related]
5. [In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses].
Yamaguchi H; Uchida K
Jpn J Antibiot; 1993 Aug; 46(8):647-53. PubMed ID: 8230734
[TBL] [Abstract][Full Text] [Related]
6. [The study of urinary tract infection with a possible cause of fungi and evaluation of the efficacy of 5-FC].
Suzuki K; Tamai H
Hinyokika Kiyo; 1985 Oct; 31(10):1885-94. PubMed ID: 3911766
[TBL] [Abstract][Full Text] [Related]
7. [A study on urinary fungal infection].
Takeuchi H; Arai Y; Konami T; Ikeda T; Tomoyoshi T; Tatewaki K
Hinyokika Kiyo; 1983 Oct; 29(10):1273-7. PubMed ID: 6100418
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorocytosine resistance in candida spp. and Torulopsis glabrata.
Schönebeck J; Anséhn S
Sabouraudia; 1973 Mar; 11(1):10-20. PubMed ID: 4574129
[No Abstract] [Full Text] [Related]
9. [Drug susceptibility of Trichosporon beigelii isolated from urine and clinical features of their hosts].
Kouda M; Matsushima H; Homma S; Marumo K; Komine Y; Iizuka T
Kansenshogaku Zasshi; 2003 Jul; 77(7):480-7. PubMed ID: 12931573
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Candida urinary tract infections with reference to serum levels of anti-Candida antibody and D-arabinitol].
Tokunaga S; Ohkawa M; Hisazumi H
Hinyokika Kiyo; 1987 Dec; 33(12):1988-94. PubMed ID: 3448923
[TBL] [Abstract][Full Text] [Related]
11. [The in vitro antifungal activities of fluconazole against pathogenic yeasts recently isolated from clinical specimens].
Yamaguchi H; Igari J; Kume H; Abe M; Oguri T; Kanno H; Kawakami S; Okuzumi K; Fukayama M; Ito A; Kawata K; Uchida K
Jpn J Antibiot; 1997 Sep; 50(9):799-805. PubMed ID: 9394240
[TBL] [Abstract][Full Text] [Related]
12. [Fluconazole in treatment of urinary candidiasis. Experience with 24 patients].
Thompson L; Pino M; Castrillón MA; Schenone D; del Canto E
Rev Med Chil; 1995 Dec; 123(12):1505-9. PubMed ID: 8733268
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
[TBL] [Abstract][Full Text] [Related]
14. Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
Osawa K; Shigemura K; Yoshida H; Fujisawa M; Arakawa S
J Antibiot (Tokyo); 2013 Nov; 66(11):651-4. PubMed ID: 23801184
[TBL] [Abstract][Full Text] [Related]
15. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of urinary fungal infection: survey of patient background and fungal strains from the urine].
Fujihiro S; Ehara H; Tokuyama K; Yamada S; Harada Y; Kanematu M; Ban Y; Kawada Y
Hinyokika Kiyo; 1991 Nov; 37(11):1519-24. PubMed ID: 1722637
[TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy of fluconazole in urinary tract fungal infections].
Nito H
Jpn J Antibiot; 1989 Jan; 42(1):171-8. PubMed ID: 2540364
[TBL] [Abstract][Full Text] [Related]
18. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
Segal E; Romano A; Eylan E; Stein R
Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
[TBL] [Abstract][Full Text] [Related]
19. [The resistance behavior of yeast isolates from defined patient groups to 5-fluorocytosine].
Weber S; Polak-Wyss A
Mycoses; 1991; 34 Suppl 1():77-81. PubMed ID: 1818269
[TBL] [Abstract][Full Text] [Related]
20. Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.
Karyotakis NC; Dignani MC; Hachem R; Anaissie EJ
Antimicrob Agents Chemother; 1995 Feb; 39(2):571-3. PubMed ID: 7726538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
